These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 32427076

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC, van Geest Q, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Barkhof F, Uitdehaag BMJ, Schoonheim MM, Geurts JJG.
    Brain; 2018 Sep 01; 141(9):2605-2618. PubMed ID: 30169585
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
    Gioia MC, Cerasa A, Liguori M, Passamonti L, Condino F, Vercillo L, Valentino P, Clodomiro A, Quattrone A, Fera F.
    Brain Res; 2007 Sep 05; 1167():71-9. PubMed ID: 17689504
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
    Papathanasiou A, Messinis L, Zampakis P, Panagiotakis G, Gourzis P, Georgiou V, Papathanasopoulos P.
    J Neurol Sci; 2015 Nov 15; 358(1-2):236-42. PubMed ID: 26359854
    [Abstract] [Full Text] [Related]

  • 11. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
    Hofstetter L, Naegelin Y, Filli L, Kuster P, Traud S, Smieskova R, Mueller-Lenke N, Kappos L, Gass A, Sprenger T, Penner IK, Nichols TE, Vrenken H, Barkhof F, Polman C, Radue EW, Borgwardt SJ, Bendfeldt K.
    Mult Scler; 2014 Feb 15; 20(2):202-13. PubMed ID: 23804554
    [Abstract] [Full Text] [Related]

  • 12. Thalamus volume change and cognitive impairment in early relapsing-remitting multiple sclerosis patients.
    Rojas JI, Murphy G, Sanchez F, Patrucco L, Fernandez MC, Miguez J, Funes J, Golimstok A, Cristiano E.
    Neuroradiol J; 2018 Aug 15; 31(4):350-355. PubMed ID: 29869576
    [Abstract] [Full Text] [Related]

  • 13. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
    Yaldizli Ö, Penner IK, Yonekawa T, Naegelin Y, Kuhle J, Pardini M, Chard DT, Stippich C, Kira JI, Bendfeldt K, Amann M, Radue EW, Kappos L, Sprenger T.
    Eur J Neurol; 2016 Mar 15; 23(3):510-9. PubMed ID: 26699999
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
    Zhao X, Yang T, Cheng F, Yang S, Zhu W, Li S, Fan Y.
    J Tradit Chin Med; 2021 Apr 15; 41(2):316-325. PubMed ID: 33825413
    [Abstract] [Full Text] [Related]

  • 16. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC, Gold SM, Lee B, Montag M, Horsfall J, O'Connor MF, Sicotte NL.
    Neuroimage Clin; 2015 Apr 15; 8():440-7. PubMed ID: 26106524
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.
    Nygaard GO, Walhovd KB, Sowa P, Chepkoech JL, Bjørnerud A, Due-Tønnessen P, Landrø NI, Damangir S, Spulber G, Storsve AB, Beyer MK, Fjell AM, Celius EG, Harbo HF.
    Mult Scler; 2015 Apr 15; 21(4):402-14. PubMed ID: 25139946
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.
    Debernard L, Melzer TR, Alla S, Eagle J, Van Stockum S, Graham C, Osborne JR, Dalrymple-Alford JC, Miller DH, Mason DF.
    Psychiatry Res; 2015 Dec 30; 234(3):352-61. PubMed ID: 26602610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.